e-learning
resources
Breathe
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Minimal clinically important difference in idiopathic pulmonary fibrosis
Mohleen Kang, Lucian Marts, Jordan A. Kempker, Srihari Veeraraghavan
Source:
Breathe, 17 (2) 200345; 10.1183/20734735.0345-2020
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mohleen Kang, Lucian Marts, Jordan A. Kempker, Srihari Veeraraghavan. Minimal clinically important difference in idiopathic pulmonary fibrosis. Breathe, 17 (2) 200345; 10.1183/20734735.0345-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Gender differences in serial pulmonary function testing in idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 579s
Year: 2007
Idiopathic pulmonary upper lobe fibrosis shows distinct features and poor prognosis compared to idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Towards a better diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 108-113
Year: 2011
Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Evaluating disease severity in idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017
Year: 2017
Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage
Source: Eur Respir J 2003; 22: Suppl. 45, 504s
Year: 2003
A first step against idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 130-131
Year: 2011
Effect of metformin on clinically relevant outcomes in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
The diagnostic role of cryobiopsy in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013
Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation
Source: Eur Respir J 2012; 40: 794-795
Year: 2012
Negative outcome of prednisone in possible idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF clinical
Year: 2016
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 1067-1072
Year: 2010
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF treatment II
Year: 2016
Clinical features of patients with idiopathic pulmonary upper lobe-dominant fibrosis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip
Source: ERS Lung Science Conference 2021
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept